Karin Jutta Metzner - Infectious Diseases

Author Information

Karin Jutta Metzner is affiliated with the Department of Infectious Diseases and Hospital Epidemiology at the University Hospital Zurich in Zurich, Switzerland. Her work primarily focuses on infectious diseases, with a significant emphasis on HIV-1 research.

Research Contributions

Karin Jutta Metzner has made substantial contributions to the field of infectious diseases, particularly in the study of HIV-1. Her research includes evaluating maintenance strategies such as dolutegravir monotherapy, the interplay between HIV-1 replication capacity and disease markers, and approaches to quantifying the interaction between behavioral and transmission clusters. She has also explored the selection in the HIV-1 genome during transmission events, convergent evolution in acute HIV-1 infection, and the impact of human genetic variation on the sequence diversity of the Epstein-Barr virus. Additionally, she has developed novel assays for determining the replication capacities of primary HIV-1 isolates and computational pipelines for assessing viral genetic diversity.

Aliases

Karin Jutta Metzner Karin Metzner K. J. Metzner K J Metzner K Metzner Karin J. Metzner Karin J Metzner

Publication and Citation Metrics

Metric	Value
Citation Count	4466
H-Index	35
Paper Count	153

Publications:

Dolutegravir monotherapy as maintenance strategy: a meta-analysis of individual participant data from randomized controlled trials

DOI: 10.1093/ofid/ofac107

Year: 2022

The interplay between replication capacity of HIV-1 and surrogate markers of disease.

DOI: 10.1093/infdis/jiac100

Year: 2022

An Approach to Quantifying the Interaction between Behavioral and Transmission Clusters

DOI: 10.3390/v14040784

Year: 2022

Detecting Selection in the HIV-1 Genome during Sexual Transmission Events

DOI: 10.3390/v14020406

Year: 2022

Convergent evolution as an indicator for selection during acute HIV-1 infection

DOI: 10.24072/pcjournal.6

Year: 2021

The influence of human genetic variation on Epstein–Barr virus sequence diversity

DOI: 10.1038/s41598-021-84070-7

Year: 2021

A Novel High Throughput, Parallel Infection Assay for Determining the Replication Capacities of 346 Primary HIV-1 Isolates of the Zurich Primary HIV-1 Infection Study in Primary Cells

DOI: 10.3390/v13030404

Year: 2021

Emergence of Human Immunodeficiency Virus-1 Drug Resistance During the 3-Month World Health Organization-Recommended Enhanced Adherence Counseling Period in the CART-1 Cohort Study

DOI: 10.1093/ofid/ofab046

Year: 2021

V-pipe: a computational pipeline for assessing viral genetic diversity from high-throughput data

DOI: 10.1093/bioinformatics/btab015

Year: 2021

HIV-1 integration sites in CD4+ T cells during primary, chronic, and late presentation of HIV-1 infection

DOI: 10.1172/jci.insight.143940

Year: 2021